Align Technology (NASDAQ:ALGN) Given New $185.00 Price Target at Jefferies Financial Group

Align Technology (NASDAQ:ALGN) had its price target lifted by analysts at Jefferies Financial Group from $155.00 to $185.00 in a research note issued to investors on Thursday,MarketScreener reports. The brokerage currently has a “hold” rating on the medical equipment provider’s stock. Jefferies Financial Group’s price objective would indicate a potential upside of 5.34% from the stock’s previous close.

A number of other equities analysts also recently commented on the company. Needham & Company LLC restated a “hold” rating on shares of Align Technology in a report on Thursday, October 30th. Wells Fargo & Company lifted their price target on shares of Align Technology from $181.00 to $200.00 and gave the company an “overweight” rating in a research report on Thursday. HSBC increased their price objective on shares of Align Technology from $140.00 to $150.00 in a research report on Friday, October 31st. Mizuho lifted their target price on shares of Align Technology from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Thursday. Finally, Morgan Stanley upped their price target on shares of Align Technology from $154.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Thursday. Six analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $195.58.

Align Technology Price Performance

Shares of NASDAQ ALGN opened at $175.62 on Thursday. The company has a 50-day simple moving average of $162.45 and a 200-day simple moving average of $148.78. The company has a market cap of $12.60 billion, a PE ratio of 31.03, a price-to-earnings-growth ratio of 1.81 and a beta of 1.84. Align Technology has a 12 month low of $122.00 and a 12 month high of $232.20.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share for the quarter, topping analysts’ consensus estimates of $2.99 by $0.30. The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.03 billion. Align Technology had a return on equity of 15.32% and a net margin of 10.17%.The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.44 EPS. On average, analysts anticipate that Align Technology will post 7.98 EPS for the current year.

Institutional Trading of Align Technology

Several large investors have recently modified their holdings of the business. Atria Investments Inc increased its position in Align Technology by 4.9% during the second quarter. Atria Investments Inc now owns 1,575 shares of the medical equipment provider’s stock worth $298,000 after buying an additional 74 shares during the last quarter. Comerica Bank increased its holdings in shares of Align Technology by 0.6% during the 4th quarter. Comerica Bank now owns 13,656 shares of the medical equipment provider’s stock worth $2,132,000 after acquiring an additional 76 shares during the last quarter. IFP Advisors Inc increased its holdings in shares of Align Technology by 5.7% during the 2nd quarter. IFP Advisors Inc now owns 1,427 shares of the medical equipment provider’s stock worth $270,000 after acquiring an additional 77 shares during the last quarter. Arizona State Retirement System lifted its holdings in Align Technology by 0.4% during the 3rd quarter. Arizona State Retirement System now owns 20,387 shares of the medical equipment provider’s stock valued at $2,553,000 after purchasing an additional 79 shares during the last quarter. Finally, Sentry Investment Management LLC boosted its position in Align Technology by 73.1% during the third quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 79 shares during the period. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Align Technology

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q4 results beat Street estimates — EPS $3.29 vs. $2.99 expected and revenue $1.0476B vs. ~$1.03B; management cited volume strength and revenue up year-over-year. Press Release
• Positive Sentiment: Management tone constructive — CEO Joseph Hogan said markets are “more stable,” with rising Invisalign demand among teenagers and accelerating international growth, supporting near-term volume momentum. Fox Interview
• Positive Sentiment: Record Clear Aligner / Invisalign volumes reported, a core demand signal that underpinned the beat. Benzinga
• Positive Sentiment: Analysts are revising forecasts and targets upward after results — Leerink raised its PT to $225 (outperform) and Mizuho raised its PT to $215 (outperform), reflecting renewed upside expectations. Leerink PT Mizuho PT
• Neutral Sentiment: Company guidance for Q1 came in roughly in line with consensus — limits surprise upside near-term; investors will focus on execution vs. guidance. Reuters
• Neutral Sentiment: Align outlined a 3%–4% revenue growth target for 2026 with DSO momentum and digital initiatives noted — modest growth target that suggests steady, not breakout, topline expansion. Seeking Alpha
• Negative Sentiment: Margins contracted — gross and operating margins fell despite the top-line beat, which could pressure near-term profitability and investor expectations if the trend continues. Zacks

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.